Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14801-14850 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04247503
Cohort Study of Pancreatic Cancer Risk
N/A
Active, not recruiting
419 participants
Started: Dec 11, 2019 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT03807661
Percutaneous Deep Vein Arterialization Post-Market Study
NA
Active, not recruiting
28 participants
Started: Dec 11, 2019 · Completed: Oct 9, 2024
1 condition
1 sponsor
6 locations
NCT04179955
Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse
N/A
Active, not recruiting
80 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04188548
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
PHASE1
Active, not recruiting
500 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2027
4 conditions
1 sponsor
74 locations
NCT04224480
Longitudinal Immune-phenotyping of HCC Following MK-3475
PHASE1
Active, not recruiting
8 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT04808479
Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use
NA
Active, not recruiting
200 participants
Started: Dec 10, 2019 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT04171661
Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa
EARLY_PHASE1
Active, not recruiting
1 participants
Started: Dec 10, 2019 · Completed: Dec 18, 2026
1 condition
2 sponsors
1 location
NCT04172038
SMART Stepped Care Management for Low Back Pain in the Military Health System
NA
Active, not recruiting
850 participants
Started: Dec 9, 2019 · Completed: Jul 31, 2025
4 conditions
6 sponsors
4 locations
NCT04476199
Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT
PHASE2
Active, not recruiting
100 participants
Started: Dec 9, 2019 · Completed: Jun 30, 2025
1 condition
1 sponsor
25 locations
NCT04189029
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study
N/A
Active, not recruiting
175 participants
Started: Dec 9, 2019 · Completed: Dec 31, 2025
2 conditions
13 sponsors
1 location
NCT04204707
Patient Reported Outcomes After Surgery for Rectal Endometriosis
N/A
Active, not recruiting
294 participants
Started: Dec 9, 2019 · Completed: Mar 31, 2025
4 conditions
2 sponsors
2 locations
NCT04061603
iCLAS™ for Persistent Atrial Fibrillation
NA
Active, not recruiting
200 participants
Started: Dec 9, 2019 · Completed: Aug 30, 2024
1 condition
1 sponsor
21 locations
NCT03816358
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
PHASE1
Active, not recruiting
74 participants
Started: Dec 9, 2019 · Completed: Jan 31, 2026
4 conditions
1 sponsor
45 locations
NCT04192981
GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
PHASE1
Active, not recruiting
21 participants
Started: Dec 6, 2019 · Completed: Dec 31, 2026
2 conditions
2 sponsors
9 locations
NCT04238949
Community Health Workers in Pediatric Patients With Newly Diagnosed Type 1 Diabetes
NA
Active, not recruiting
28 participants
Started: Dec 6, 2019 · Completed: Jan 31, 2026
5 conditions
2 sponsors
1 location
NCT03836209
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
PHASE2
Active, not recruiting
181 participants
Started: Dec 6, 2019 · Completed: Dec 31, 2026
1 condition
2 sponsors
44 locations
NCT03494959
Pentaglobin in CRE and PA Neutropenic Infections
PHASE2
Active, not recruiting
120 participants
Started: Dec 6, 2019 · Completed: May 31, 2025
1 condition
1 sponsor
20 locations
NCT03930121
Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia
NA
Active, not recruiting
130 participants
Started: Dec 6, 2019 · Completed: Aug 4, 2026
2 conditions
1 sponsor
19 locations
NCT03970538
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NA
Active, not recruiting
105 participants
Started: Dec 6, 2019 · Completed: Feb 28, 2025
12 conditions
1 sponsor
21 locations
NCT04220827
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
PHASE1
Active, not recruiting
27 participants
Started: Dec 6, 2019 · Completed: Oct 30, 2028
17 conditions
2 sponsors
1 location
NCT04125277
The SONImage Study
NA
Active, not recruiting
100 participants
Started: Dec 5, 2019 · Completed: Jul 31, 2025
1 condition
3 sponsors
2 locations
NCT04225455
The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes
N/A
Active, not recruiting
17 participants
Started: Dec 5, 2019 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT04990726
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
N/A
Active, not recruiting
126 participants
Started: Dec 5, 2019 · Completed: Feb 2, 2027
8 conditions
1 sponsor
1 location
NCT04097470
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
PHASE2
Active, not recruiting
140 participants
Started: Dec 5, 2019 · Completed: Nov 30, 2026
1 condition
2 sponsors
37 locations
NCT03480334
Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy
PHASE2
Active, not recruiting
26 participants
Started: Dec 5, 2019 · Completed: May 4, 2025
1 condition
1 sponsor
1 location
NCT04283890
PHP and Immunotherapy in Metastasized UM
PHASE1/PHASE2
Active, not recruiting
83 participants
Started: Dec 4, 2019 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT04034927
Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
PHASE2
Active, not recruiting
61 participants
Started: Dec 4, 2019 · Completed: Feb 21, 2026
14 conditions
2 sponsors
20 locations
NCT03976843
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
PHASE2
Active, not recruiting
175 participants
Started: Dec 4, 2019 · Completed: Nov 19, 2027
1 condition
2 sponsors
6 locations
NCT03880656
BM-MNCs for Lower Extremity Compartment Syndrome Injury
PHASE1
Active, not recruiting
18 participants
Started: Dec 4, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04083950
Induction of Gut Permeability by an Oral Vaccine
EARLY_PHASE1
Active, not recruiting
10 participants
Started: Dec 4, 2019 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT04146051
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
PHASE2
Active, not recruiting
30 participants
Started: Dec 4, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
15 locations
NCT04073745
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer
PHASE1
Active, not recruiting
50 participants
Started: Dec 4, 2019 · Completed: Dec 27, 2025
10 conditions
1 sponsor
1 location
NCT03705104
Living Well with Chronic Pain
NA
Active, not recruiting
340 participants
Started: Dec 3, 2019 · Completed: Jan 31, 2030
1 condition
11 sponsors
1 location
NCT04194268
Pancreatic Cancer and Carbon Ion Radiotherapy
NA
Active, not recruiting
25 participants
Started: Dec 3, 2019 · Completed: Dec 9, 2025
1 condition
1 sponsor
1 location
NCT04170881
CRESPI - Respiratory Health of Children in Daycare
N/A
Active, not recruiting
2,000 participants
Started: Dec 3, 2019 · Completed: Dec 3, 2029
1 condition
9 sponsors
1 location
NCT04187612
Association of Body Fluid Distribution with Obstructive Sleep Apnea in Pregnant Women with Body Mass Index ≥ 40 Kg/m2
N/A
Active, not recruiting
52 participants
Started: Dec 2, 2019 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03928288
Cabergoline for the Treatment of Chronic Pain Due to Endometriosis
PHASE2
Active, not recruiting
140 participants
Started: Dec 2, 2019 · Completed: Jun 30, 2026
1 condition
6 sponsors
6 locations
NCT04250922
LAM561 With RT and TMZ for Adults With Glioblastoma
PHASE2/PHASE3
Active, not recruiting
140 participants
Started: Dec 1, 2019 · Completed: May 30, 2025
2 conditions
5 sponsors
22 locations
NCT04203173
Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1
NA
Active, not recruiting
450 participants
Started: Dec 1, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04066049
EMT en Español for Spanish-speaking Toddlers With Language Delays
NA
Active, not recruiting
90 participants
Started: Dec 1, 2019 · Completed: Jul 31, 2025
1 condition
2 sponsors
1 location
NCT06949241
A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center
N/A
Active, not recruiting
76 participants
Started: Dec 1, 2019 · Completed: Feb 2, 2026
3 conditions
1 sponsor
1 location
NCT04264845
Patient-Reported Outcomes as an Indicator of Disease Transitions in Heart Failure
N/A
Active, not recruiting
3,640 participants
Started: Dec 1, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04273776
A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study
EARLY_PHASE1
Active, not recruiting
90 participants
Started: Dec 1, 2019 · Completed: Dec 12, 2025
1 condition
1 sponsor
1 location
NCT04222205
Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation
NA
Active, not recruiting
2,143 participants
Started: Dec 1, 2019 · Completed: Jun 30, 2025
1 condition
1 sponsor
3 locations
NCT04100811
Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform
N/A
Active, not recruiting
2,019 participants
Started: Dec 1, 2019 · Completed: Dec 31, 2024
1 condition
1 sponsor
3 locations
NCT04167878
Exploratory Study of 3D Printed Biodegradable Cervical Interbody Fusion Cage
NA
Active, not recruiting
10 participants
Started: Dec 1, 2019 · Completed: Dec 30, 2030
1 condition
1 sponsor
1 location
NCT03396068
NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
PHASE3
Active, not recruiting
72 participants
Started: Dec 1, 2019 · Completed: Dec 31, 2024
2 conditions
2 sponsors
4 locations
NCT04384627
Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy
PHASE3
Active, not recruiting
445 participants
Started: Dec 1, 2019 · Completed: Oct 1, 2026
3 conditions
3 sponsors
2 locations
NCT04095923
A Social Media Game to Increase Physical Activity Among Older Adult Women
NA
Active, not recruiting
300 participants
Started: Dec 1, 2019 · Completed: Feb 28, 2026
1 condition
3 sponsors
1 location
NCT03410667
Incontinence and Quality of Life in Children With Spina Bifida
NA
Active, not recruiting
67 participants
Started: Dec 1, 2019 · Completed: Mar 15, 2026
2 conditions
2 sponsors
1 location
Previous
1
More pages
294
295
296
297
298
299
300
More pages
431
Next